PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3). - Wikidata - wikimedia - TriplyDB

PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3).

PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3).

http://www.wikidata.org/entity/Q33705238

about

Vitamin D and Immune Response: Implications for Prostate Cancer in African Americans Polymorphisms in oxidative stress and inflammation pathway genes, low-dose ionizing radiation, and the risk of breast cancer among US radiologic technologists Performance of an adipokine pathway-based multilocus genetic risk score for prostate cancer risk prediction Genetic polymorphisms in inflammation pathway genes and prostate cancer risk.Prostate cancer and inflammation: the evidence.Polymorphisms in regulatory regions of cyclooxygenase-2 gene and breast cancer risk in Brazilians: a case-control study Association of interleukin-6 (-174 G/C) polymorphism with the prostate cancer risk: A meta-analysis.Association of the three common SNPs of cyclooxygenase-2 gene (rs20417, rs689466, and rs5275) with the susceptibility of breast cancer: an updated meta-analysis involving 34,590 subjects.Association between COX-2 rs2745557 polymorphism and prostate cancer risk: a systematic review and meta-analysis The interleukin-6 -174G/C polymorphism and prostate cancer risk: a systematic review and meta-analysis.Genetic variants in COX-2, non-steroidal anti-inflammatory drugs, and breast cancer risk: the Western New York Exposures and Breast Cancer (WEB) Study.Inhibition of constitutively active Stat3 reverses enzalutamide resistance in LNCaP derivative prostate cancer cells COX-2-765G>C polymorphism increases the risk of cancer: a meta-analysis.PharmGKB summary: very important pharmacogene information for PTGS2.Circulating interleukin-6 and cancer: A meta-analysis using Mendelian randomization.Association between IL6 -174G/C and cancer: A meta-analysis of 105,482 individuals.Association between interleukin-6 polymorphisms and urinary system cancer risk: evidence from a meta-analysis MiRNA-26b inhibits proliferation by targeting PTGS2 in breast cancer Effect of low doses of estradiol and tamoxifen on breast cancer cell karyotypes Adiposity, inflammation, genetic variants and risk of post-menopausal breast cancer findings from a prospective-specimen-collection, retrospective-blinded-evaluation (PRoBE) design approach.Targeting of the innate immunity/inflammation as complementary anti-tumor therapies.Five COX-2 gene polymorphisms and risk of breast cancer: an updated meta-analysis based on 19 case-control studies.Prostaglandin-endoperoxide synthase 2 (PTGS2) rs20417 polymorphism and prostate cancer risk: a meta analysis.Cyclooxygenase 2 (rs2745557) Polymorphism and the Susceptibility to Benign Prostate Hyperplasia and Prostate Cancer in Egyptians.Integrative Comparison of mRNA Expression Patterns in Breast Cancers from Caucasian and Asian Americans with Implications for Precision Medicine.Anti-cancer effect of ursolic acid activates apoptosis through ROCK/PTEN mediated mitochondrial translocation of cofilin-1 in prostate cancer.Meta-analysis of the role of IL-6 rs1800795 polymorphism in the susceptibility to prostate cancer: Evidence based on 17 studies.Variability of the drug response to nonsteroidal anti-inflammatory drugs according to cyclooxygenase-2 genetic polymorphism.Cyclooxygenase-2 polymorphisms and breast cancer associated risk in Pakistani patients.Interleukin-6 gene -174G>C and -636G>C promoter polymorphisms and prostate cancer risk.Cyclooxygenase-2 (COX-2) polymorphisms and risk of inflammatory bowel disease in a Scottish and Danish case-control study.Genetic polymorphisms of IL-6 promoter in cancer susceptibility and prognosis: a meta-analysis.Single nucleotide polymorphism rs4648298 in miRNAs hsa-miR21 and hsa-miR590 binding site of COX gene is a strong colorectal cancer determinant.Association between cyclooxygenase-2 (COX-2) 8473 T > C polymorphism and cancer risk: a meta-analysis and trial sequential analysis

P2860

Q26768536-A3B39716-89C4-4D30-8777-2DBA70AC4C22 Q28387859-87905391-96CB-4198-A59D-3A0CD901F585 Q28727717-08DCB2CE-5329-4FDB-AC3A-D1ADDCF1075C Q30502672-967436AA-ACE6-44DC-BC13-C5626C204B85 Q33642321-D6184477-42A8-4E42-BBBB-A5580BA7664B Q33741123-36CD96F3-2C4C-4594-BB49-642AFBACB975 Q33932481-D843FCDB-9685-4F1D-826C-A24FA343299D Q34119332-BDC483B6-6657-4016-9D22-4B4300A427C1 Q34204738-818406D0-FFE9-4742-8838-D721523EC33C Q34239802-3F36BC9A-55EA-412C-9EAB-BFB97FE96E3F Q34351250-56CA3FCB-0D2A-4B2D-9AED-60C07EC0F36B Q34389853-6D1620F6-3884-4C68-8FF5-20AAAF2C4A0D Q34984281-EDE99CED-C2D6-4AC8-B1DC-6708A4F2CA55 Q35120350-8E80728C-7ECE-4142-B0EE-428ABA0AFACC Q35764701-89FA7D46-AD5A-4D08-9E52-4DB003EFF338 Q36224715-6881216F-FC25-49CC-ACBB-1B83D442E66A Q36525733-33D3DC8B-A126-4C1F-A3D2-83D8A35CC778 Q36690777-5FFA5FB5-0596-45CE-9F3D-96C0ADD51E32 Q37340513-5FE0A461-51CC-4C4D-8727-E5E604C7B860 Q37381710-2F8A4F46-00CA-4B30-B294-0E78F2F33BBC Q37901025-5CE52B97-F820-4726-A7B3-0FF66A840113 Q38393725-420FCCDA-C63C-4DD4-AF82-6A86D349B143 Q38907143-FD2B0123-0902-4397-AB43-8D7DC85069B5 Q39001013-BEE02D97-3873-438A-8091-AED84E47CE59 Q39030597-E6CF3301-31F5-4405-B621-E7519BFDE121 Q41195198-17DA2D79-99AD-49E1-B1C3-DF461B9A2F07 Q42293538-CE0E834E-15EA-4520-8D56-55C1CC3A4282 Q42736023-B37CB598-A189-4A31-8F42-AA9816E67CA6 Q43875819-83A2891F-C5B7-46C0-BEF8-A53B38D62470 Q44788547-61EC6103-D303-4B71-A70C-EE77A241EE44 Q44934975-6130A416-FD3B-49ED-9A5F-7702B39B3486 Q55195036-4CF03512-6CBF-426B-A3DD-20562F4D76CA Q55534659-91EF2C41-0F1B-4FF9-A504-4BD78094A00D Q58707390-E5C7E35A-4FD8-4F28-A4CF-021D02D7E6BB

P2860

PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3).

http://www.wikidata.org/entity/Q33705238

description

2009 nî lūn-bûn

@nan

2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

PTGS2 and IL6 genetic variatio ...... ncer Cohort Consortium (BPC3).

@ast

PTGS2 and IL6 genetic variatio ...... ncer Cohort Consortium (BPC3).

@en

type

label

PTGS2 and IL6 genetic variatio ...... ncer Cohort Consortium (BPC3).

@ast

PTGS2 and IL6 genetic variatio ...... ncer Cohort Consortium (BPC3).

@en

prefLabel

PTGS2 and IL6 genetic variatio ...... ncer Cohort Consortium (BPC3).

@ast

PTGS2 and IL6 genetic variatio ...... ncer Cohort Consortium (BPC3).

@en

P1433

Q33705238-F3B15473-FF27-49CC-8143-CF04FBDA2CF2

P1476

Q33705238-77EFFD57-FFF9-4239-8F36-F41BC81E5B76

P2093

Q33705238-0FC968C2-2FF2-4F13-86CA-CAB4F3098270

Q33705238-3285F8C4-7D06-433C-840E-9BD80A5C0C71

Q33705238-4822E45C-1182-491E-88DA-21A8DEC683F7

Q33705238-533798AE-869C-4181-BB1D-35BC37CE2913

Q33705238-581F018F-00D6-46D2-A706-3A2D47DBC7F8

Q33705238-7245E339-693C-4EA2-9F0B-F95853B29749

Q33705238-814D089E-7CC0-4220-9E5B-8A386C3277EC

Q33705238-85008BDD-9CB4-4962-884F-E3EE80DD877A

Q33705238-93DA1139-B37B-46BB-9C93-21D56C831E1A

Q33705238-9AC0ED2C-281F-443F-A9C9-BCDDF502DAE8

P2860

Q33705238-004C4A7B-2477-4DF7-9F06-BDEB61DD4625

Q33705238-02CBFC0C-1074-43AA-9C71-5EC35383D430

Q33705238-05D19B1E-9647-46F7-8568-8454122E1888

Q33705238-08FF1161-0BE5-4F79-B8BC-391348FE15E9

Q33705238-0930D781-38FB-478C-B56A-59DE4D0AE884

Q33705238-0D2B0656-BD34-45BB-9CDE-221FBA0C66E9

Q33705238-11B38BB2-CBC2-4C9F-A2EA-EE73E934F59D

Q33705238-14D19A72-1371-418B-BFFE-FD14443ACD1B

Q33705238-15862D1D-FEA1-4B76-896A-5F6AFF5237F2

Q33705238-21A96934-94A7-4DC0-B0C4-95A6A6D6524F

P304

Q33705238-00198435-84C4-4776-92CC-13247E495FE1

P31

Q33705238-21A3745A-CCA3-4D1D-BC5C-07BB96CC3999

P356

Q33705238-FAA9C7E6-92F0-4647-93B4-A950C4CF5D4E

P407

Q33705238-F30E6A74-344D-4345-B16D-0E6B807F7ECA

P433

Q33705238-2BBFCA33-F34A-4BFD-8515-D9D48CDEF8B1

P478

Q33705238-6EDDF7B4-DD10-4EBA-8B52-9C293E445716

P50

Q33705238-07549DCD-7725-4E73-9D19-84FA12816285

Q33705238-1AD0B009-7D36-43C0-AEB1-503E025779A5

Q33705238-1AE6E47F-82A8-416A-B8E9-C607E804E854

Q33705238-24C57BC2-C3E1-4858-AFEC-9DE5314DF9B9

Q33705238-33B3974E-18C4-47CE-B17F-E4791F457970

Q33705238-39D876B9-14CB-4483-9D6C-23DC1661BDD4

Q33705238-3A3A5B17-A502-400B-B834-0E6C79B7F5FA

Q33705238-4852C54C-B48D-4C7D-9232-4705BC50992D

Q33705238-6C99E627-E8D8-4828-A59B-4C1C81A2E91B

Q33705238-7192EB70-6FD2-426D-B40A-69B33063B812

P577

Q33705238-B7296D1E-A5CB-4D9E-99FE-C089B96A904B

P5875

Q33705238-0B2205C1-2CC4-4007-939B-98604CB6B9B0

P698

Q33705238-DAB7E406-0D53-4F32-9FE2-ECAA1BFDB3C4

P932

Q33705238-A97FC819-9E55-4474-9343-2C97E61C6CFF

P356

P1433

P1476

PTGS2 and IL6 genetic variatio ...... ncer Cohort Consortium (BPC3).

@en

P2093

Carlos Gonzalez

http://www.w3.org/2001/XMLSchema#string

Dan O Stram

http://www.w3.org/2001/XMLSchema#string

Gilles Thomas

http://www.w3.org/2001/XMLSchema#string

Jing Ma

http://www.w3.org/2001/XMLSchema#string

John M Gaziano

http://www.w3.org/2001/XMLSchema#string

Laure Dossus

http://www.w3.org/2001/XMLSchema#string

Laurence N Kolonel

http://www.w3.org/2001/XMLSchema#string

Michael J Thun

http://www.w3.org/2001/XMLSchema#string

Petra H M Peeters

http://www.w3.org/2001/XMLSchema#string

Regina G Ziegler

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammation and cancer

Genetic variation in the HSD17B1 gene and risk of prostate cancer.

Quantifying heterogeneity in a meta-analysis

Cyclooxygenase-2-mediated DNA damage

A large cohort study of aspirin and other nonsteroidal anti-inflammatory drugs and prostate cancer incidence

The American Cancer Society Cancer Prevention Study II Nutrition Cohort: rationale, study design, and baseline characteristics

Analgesic drug use and risk of ovarian cancer

Cyclooxygenase-2 and prostate carcinogenesis

A polymorphism in the 3' untranslated region of the gene encoding prostaglandin endoperoxide synthase 2 is not associated with an increase in breast cancer risk: a nested case-control study

COX2 genetic variation, NSAIDs, and advanced prostate cancer risk

P304

455-461

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CARCIN/BGP307

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

31

http://www.w3.org/2001/XMLSchema#string

P50

Dimitrios Trichopoulos

Edward Giovannucci

David J. Hunter

Stephen Chanock

Meredith Yeager

Demetrius Albanes

Anne Tjønneland

P577

2009-12-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

40452865

http://www.w3.org/2001/XMLSchema#string

P698

19965896

http://www.w3.org/2001/XMLSchema#string

P932

2832545

http://www.w3.org/2001/XMLSchema#string